An imaging technique that uses radioactive tracers to observe metabolic processes.Positron emission tomography (PET) is a medical imaging technique that produces three-dimensional images of functional processes in the body, such as glucose metabolism or blood flow. It works by detecting pairs of gamma rays emitted indirectly by a radioactive tracer that has been injected into the patient. PET is widely used in oncology, neurology, and cardiology to diagnose diseases, assess treatment response, and guide surgical planning.
The underlying physics was established in the 1950s, and the first PET scanner was developed in the early 1970s by researchers including Michael Phelps and Edward Hoffman at Washington University. The technique became clinically widespread in the 1980s and 1990s.
A radioactive isotope attached to a biologically active molecule — typically a glucose analog like FDG — is introduced into the body. As the isotope decays, it emits a positron, which travels a short distance before annihilating with an electron. The annihilation produces two gamma-ray photons traveling in exactly opposite directions. A ring of detectors around the patient records these simultaneous photon pairs, and computer algorithms reconstruct the spatial distribution of the tracer, revealing areas of high metabolic activity.
PET is essential for cancer staging and monitoring, detecting metastases, evaluating brain disorders like Alzheimer's disease, and assessing myocardial viability in cardiology.
The two gamma rays from a positron annihilation are emitted back-to-back, which is why PET detectors are arranged in a ring — they must catch both photons to locate the event.




















